Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan.
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Cardiovasc Interv Ther. 2024 Oct;39(4):403-411. doi: 10.1007/s12928-024-01022-4. Epub 2024 Jun 17.
Standard modifiable cardiovascular risk factors (SMuRFs), such as hypertension, diabetes, dyslipidemia, and current smoking, are associated with the development of atherosclerotic cardiovascular diseases including acute myocardial infarction (MI). Thus, therapeutic approaches against SMuRFs are important as primary and secondary prevention of cardiovascular diseases. In patients with acute MI, however, the prognosis is counterintuitively poor when SMuRFs are lacking. The growing evidence has explored the prevalence, pathophysiology, and prognosis of SMuRF-less patients in acute MI and suggested the potential underlying mechanisms. This review article summarizes the clinical evidence and relevance of the lack of SMuRFs in acute MI.
标准可调节心血管危险因素(SMuRFs),如高血压、糖尿病、血脂异常和当前吸烟,与动脉粥样硬化性心血管疾病的发展有关,包括急性心肌梗死(MI)。因此,针对 SMuRFs 的治疗方法对于心血管疾病的一级和二级预防很重要。然而,在急性 MI 患者中,当缺乏 SMuRFs 时,预后却出人意料地差。越来越多的证据探讨了急性 MI 中缺乏 SMuRFs 的患者的患病率、病理生理学和预后,并提出了潜在的潜在机制。这篇综述文章总结了急性 MI 中缺乏 SMuRFs 的临床证据和相关性。